Cargando…
Pediatric dosing for locally acting drugs in submissions to the U.S. Food and Drug Administration between 2002 and 2020
Deriving pediatric doses for locally acting drugs (LADs) presents a unique challenge because limited systemic exposure hinders commonly used approaches such as pharmacokinetic matching to adults. This study systematically evaluated drug development practices used for pediatric dose selection of LADs...
Autores principales: | Abulwerdi, Gelareh A., Ramamoorthy, Anuradha, Bashaw, Edward, Burckart, Gilbert J., Madabushi, Rajanikanth, Fletcher, Elimika Pfuma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582654/ https://www.ncbi.nlm.nih.gov/pubmed/37551830 http://dx.doi.org/10.1111/cts.13611 |
Ejemplares similares
-
Need for Representation of Pediatric Patients with Obesity in Clinical Trials
por: Samuels, Sherbet, et al.
Publicado: (2023) -
Clinical pharmacology information in regulatory submissions and labeling: A comparative analysis of orphan and non‐orphan drugs approved by the FDA
por: Hsieh, Julie, et al.
Publicado: (2022) -
Quantitative systems pharmacology: Landscape analysis of regulatory submissions to the US Food and Drug Administration
por: Bai, Jane P. F., et al.
Publicado: (2021) -
A Holistic and Integrative Approach for Advancing Model‐Informed Drug Development
por: Madabushi, Rajanikanth, et al.
Publicado: (2019) -
Review: Role of Model-Informed Drug Development Approaches in the Lifecycle of Drug Development and Regulatory Decision-Making
por: Madabushi, Rajanikanth, et al.
Publicado: (2022)